GSK3B and hepatocellular carcinoma: Building upon this premise, we subjected HCC cells to cycloheximide (CHX) treatment, revealing that circFADS1 knockdown delayed the degradation of GSK3β while overexpression of circFADS1 accelerated the process (Figure 4F).